Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -6.22% | +78.50% |
2019 | Argos Therapeutics, Inc. Went Out of Business | CI |
2019 | First Amended Liquidation Plan Approved for Argos Therapeutics, Inc. | CI |
Sales 2016 | 945K 74.11M | Sales 2017 | 1.9M 149M | Capitalization | 13.18M 1.03B |
---|---|---|---|---|---|
Net income 2016 | -53M -4.15B | Net income 2017 | -40M -3.14B | EV / Sales 2016 | 200 x |
Net cash position 2016 | 13.11M 1.03B | Net Debt 2017 | 4.27M 334M | EV / Sales 2017 | 9.19 x |
P/E ratio 2016 |
-2.96
x | P/E ratio 2017 |
-0.22
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 88.73% |
1st Jan change | Capi. | |
---|---|---|
+78.50% | 567K | |
-1.64% | 90.28B | |
-1.97% | 39.5B | |
-15.47% | 31.71B | |
+61.28% | 26.41B | |
-22.81% | 14.34B | |
-8.82% | 12.89B | |
-11.77% | 11.8B | |
-45.97% | 10.95B | |
+3.30% | 8.85B |
- Stock Market
- Equities
- ARGSQ Stock